PATENT CLAIM ANALYSIS

Application Number: 16065430
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "456000"]

Abstract:
Provided are: a composition having an excellent anti-norovirus effect; use of a theaflavin compound for the preparation of the composition; and a method for preventing infection with a norovirus using a theaflavin compound. A theaflavin compound is used as an active ingredient for preventing infection with a norovirus. The theaflavin compound is preferably used together with an alcohol. The theaflavin compound is preferably one or more members selected from the group consisting of theaflavin, theaflavin-3-O-gallate, theaflavin-3′-O-gallate and theaflavin-3,3′-O-digallate that are derived from tea components.

Claim (Index 9):
The method according to  claim 7 , wherein the theaflavin compound is one or more members selected from the group consisting of theaflavin, theaflavin-3-O-gallate, theaflavin-3\u2032-O-gallate and theaflavin-3,3\u2032-O-digallate that are derived from tea components.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 94.0
- Lexical Diversity: 1.78846
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12235163', '10601314', '11640917', '14517956', '11631507']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7610158742738956
- 35 USC 102 Novelty (BERT): 0.5060277406179436
- Combined Prediction Score: 0.7355170609083004
- Mean Citation Score: 204.619024
- Max Citation Score: 219.06546
- Similarity Product: 143.01511674345733

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test